Company Encyclopedia
View More
name
Balance Medical
688198.SH
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valve replacement and repair, congenital heart disease implant intervention, and surgical soft tissue repair applications; and cardiothoracic surgery, neurosurgery, general surgery, and other surgical departments.
932.45 B
688198.SHMarket value -Rank by Market Cap -/-

Financial Score

07/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking6/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE14.92%A
    • Profit Margin30.50%A
    • Gross Margin87.47%A
  • Growth ScoreA
    • Revenue YoY45.79%A
    • Net Profit YoY74.15%A
    • Total Assets YoY16.11%A
    • Net Assets YoY6.10%B
  • Cash ScoreB
    • Cash Flow Margin327.88%C
    • OCF YoY45.79%A
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreA
    • Gearing Ratio17.09%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Balance Medical: Radiofrequency Ablation System Enters Special Review Procedure for Innovative Medical Devices

    Balance Medical announced that its self-developed radiofrequency ablation system has been approved by the National Medical Products Administration's Medical Device Technical Review Center to enter the special review process for innovative medical devices. The system consists of an ablation instrument, ablation forceps, and an ablation pen, specifically designed for cardiac surgery to treat atrial fibrillation, using electrical isolation technology to restore normal heart rhythm

    Zhitong·
    SH
    688198
    -0.18%
    Zhitong·
    SH
    688198
    -0.18%

    Balance Medical: Net profit in the first half of 2025 increased by 102.90% year-on-year

    Balance Medical announced that its operating revenue in the first half of 2025 was 248 million yuan, a year-on-year increase of 30.07%. The net profit was 71.4006 million yuan, a year-on-year increase of 102.90%

    Zhitong·
    SH
    688198
    -0.18%
    Zhitong·
    SH
    688198
    -0.18%

    14 major pharmaceutical and health projects signed and landed in Changping, Beijing

    At the 42nd National Pharmaceutical Industry Information Annual Conference and the 2025 Beijing·Changping Life Sciences Forum, 14 major projects in the pharmaceutical and health industry were signed and landed in Changping District. These projects will promote the optimization of the regional industrial structure and high-quality development, covering multiple fields such as medical devices, pharmaceuticals, and biotechnology, injecting new vitality

    Zhitong·
    SH
    688198
    -0.18%
    SZ
    300760
    -0.27%
    Zhitong·
    SH
    688198
    -0.18%
    SZ
    300760
    -0.27%

    Balance Medical: Application for Registration of Digestive Surgery Biological Patch Accepted

    According to the Zhitong Finance APP, Balance Medical announced that its registered application for the digestive surgery biological patch product under research has been officially accepted by the National Medical Products Administration. This product is used as a soft tissue repair material for reinforcing the resection anastomosis in digestive surgery for stomach and intestinal operations, either in conjunction with cutting anastomosis devices or used independently in general surgery. It is the first soft tissue repair product in China to use bovine pericardium as raw material

    Zhitong·
    SH
    688198
    -0.18%
    Zhitong·
    SH
    688198
    -0.18%

    Balance Medical: Innovative product "Transcatheter Valve-in-Valve System" approved for registration

    Balance Medical announced that its innovative product Renato® transcatheter valve-in-valve system has received registration approval from the National Medical Products Administration. This product is specifically designed for patients with damaged implanted biological valves who face high-risk surgery, featuring a unique structure and characteristics that allow for secure anchoring at the inflow end of the valve, marking the beginning of the era of re-intervention treatment for artificial biological valves

    Zhitong·
    SH
    688198
    -0.18%
    Zhitong·
    SH
    688198
    -0.18%